Edoxaban DM+D
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- unknown
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/edoxaban-dmd
- Version ID
- 054944f5
Versions
- 054944f5
Description
This is a codelist that identifies all preparations from the NHS dictionary of medicines and devices for edoxaban, one of the Directing Oral Anticoagulants which are often referred to as DOACs.
Methodology
All preparations beginning with the following BNF code 0208020AA were identified and mapped dm+d products for these were included. https://github.com/opensafely/codelist-development/issues/58
Signed off by
- Richard Croker, (Feb. 22, 2021)
- Vicky Speed, (Feb. 22, 2021)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| dmd_type | dmd_id | dmd_name | bnf_code |
|---|---|---|---|
| VMP | 29903211000001100 | Edoxaban 15mg tablets | 0208020AAAAAAAA |
| VMP | 29903311000001108 | Edoxaban 30mg tablets | 0208020AAAAABAB |
| VMP | 29903411000001101 | Edoxaban 60mg tablets | 0208020AAAAACAC |
| AMP | 29902111000001100 | Lixiana 15mg tablets | 0208020AABBAAAA |
| AMP | 29902411000001105 | Lixiana 30mg tablets | 0208020AABBABAB |
| AMP | 29902711000001104 | Lixiana 60mg tablets | 0208020AABBACAC |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.